ライフサイエンスコーパス: nasal spray

1 OT does affect behavior when delivered as a nasal spray.

2 groups achieved higher abstinence rates with nasal spray.

3 o (n = 21); the other 3 received bevacizumab nasal spray.

4 Either 1) ipratropium bromide nasal spray 0.06% in buffered salt solution, two 42-micr

5 400 mg twice daily), fluticasone propionate nasal spray (200 mug once daily), or oral montelukast (1

6 t-to-treat analysis, 25 of 30 patients given nasal spray (83.3%) did not require rescue anesthesia.

7 re ibuprofen, acetaminophen, and sumatriptan nasal spray, all of which have shown safety and efficacy

8 Long-term use of decongestant nasal spray (alpha adrenergic agonist) causes nasal cong

9 We analyzed data for sumatriptan succinate nasal spray and zolmitriptan, eletriptan hydrobromide, a

10 er-acting product (lozenge, gum, inhaler, or nasal spray) and extend treatment beyond 12 weeks.

11 othpastes, mouthwashes, lozenges, throat and nasal sprays, and as biocides.

12 include nicotine chewing gum, skin patches, nasal sprays, and inhalers, as well as pharmacotherapies

13 Tetracaine hydrochloride-oxymetazoline nasal spray appears to provide adequate and safe anesthe

14 ne hydrochloride-oxymetazoline hydrochloride nasal spray bilaterally with sham injection.

15 e-epinephrine injection with buffered saline nasal spray bilaterally, or (2) a tetracaine hydrochlori

16 subcutaneous dupilumab to mometasone furoate nasal spray compared with mometasone alone reduced endos

17 or placebo (n = 30) plus mometasone furoate nasal spray for 16 weeks.

18 The use of nasal spray for administering OT in behavioral research

19 l trial of ibuprofen followed by sumatriptan nasal spray for children over 12 years of age for those

20 of insulin to this brain region, given that nasal sprays for insulin have been marketed notwithstand

21 es for the transdermal nicotine and nicotine nasal spray groups were not significantly different at 6

22 Zolmitriptan nasal spray has a rapid onset of action and high efficac

23 estions concerning their use of decongestant nasal spray in a questionnaire prior to examination; the

24 have no idea about the efficacy of capsaicin nasal spray in these patients nor about the time interva

25 administration of nicotine via cigarettes or nasal spray in two experimental sessions.

26 nasal steroid sprays instead of decongestant nasal sprays in our clinic from October, 2011 to Decembe

27 airways, we delivered capsaicin (200 microM) nasal spray into the nares of 20 subjects (10 with aller

28 We report here that capsaicin nasal spray is effective in a broader group of IR than t

29 is a prevalent condition for which capsaicin nasal spray is the most effective treatment.

30 e (5 mg, n = 4455), and 8 mometasone furoate nasal spray (MFNS; 200 mug daily, n = 2140) SAR or PAR t

31 f fluticasone propionate (n = 47) or placebo nasal spray (n = 48) in each nostril once daily for 21 d

32 reated with nicotine patch (n=623), nicotine nasal spray (n=189), bupropion (n=213), or placebo (n=19

33 abstinence rates with either transdermal or nasal spray nicotine.

34 ts have become available, including nicotine nasal spray, nicotine inhaler, and bupropion hydrochlori

35 A nasal spray of ALN-RSV01 or saline placebo was administe

36 We sought to study the effects of capsaicin nasal spray on the afferent innervation of the nasal muc

37 nseling and 8 weeks of therapy with nicotine nasal spray or transdermal nicotine.

38 E formulations in subcutaneous injection and nasal spray such as pain, adverse side effects and poor

39 trivalent influenza vaccine administered by nasal spray to children 15-71 months old.

40 the efficacy, safety, and tolerability of a nasal spray to induce anesthesia of maxillary teeth.

41 In patients with HHT, a bevacizumab nasal spray treatment of 3 administrations at 14-day int

42 g updates for self-injectable adrenaline and nasal spray use.

43 o-controlled randomized trial with capsaicin nasal spray was performed involving 33 patients with IR

44 Proportion of anesthesia successes for nasal spray was significantly different from the hypothe

45 uency of medication (oral administration and nasal spray) was also evaluated.

46 ministered by metered pump spray; 2) control nasal spray, which consisted of buffered salt solution;